Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
10.1073/pnas.2534397100 Proc
Consult about BPC-157 No payment
ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study
Dosage: In human sleep studies, researchers have used intravenous doses of 25nmol per kilogram.13 14 Intravenous administration boasts higher bioavailability than, say, the subcutaneous route,28 which is the more common mode of administration for peptides, so a home-use case would likely involve a higher dose
US$ 20.35
US$ 24.23
US$ 23.54
US$ 20.16
US$ 21.38
